$DRIO Press Out... DarioHealth Partners With Glytec on Outpatient Diabetes Management
The Dario® Blood Glucose Monitoring System will be made available to hospitals and health systems using Glytec's virtual insulin titration service for outpatients with diabetes
CAESAREA, Israel and WALTHAM, Massachusetts, March 27, 2019 /PRNewswire/ -- Global digital therapeutics innovator, DarioHealth Corp. (DRIO), today announced a joint marketing agreement with Glytec, the market leader and pioneer of insulin titration solutions for use across the full continuum of care. The agreement allows DarioHealth's smart glucose meter (part of the Dario Blood Glucose Monitoring System) to transmit information to Glytec's Glucommander™ Outpatient software-as-a-medical-device.....
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.